TEAR - TearLab Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
0.0931
-0.0169 (-15.36%)
At close: 3:04PM EST
Stock chart is not supported by your current browser
Previous Close0.1100
Open0.1036
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0931 - 0.1036
52 Week Range0.0300 - 0.7300
Volume1,199
Avg. Volume46,540
Market Cap1.052M
Beta (3Y Monthly)1.04
PE Ratio (TTM)N/A
EPS (TTM)-0.6090
Earnings DateMay 4, 2017 - May 8, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.50
Trade prices are not sourced from all markets
  • Associated Press2 months ago

    TearLab: 3Q Earnings Snapshot

    On a per-share basis, the Escondido, California-based company said it had a loss of 2 cents. The ophthalmic device company posted revenue of $6.2 million in the period. In the final minutes of trading ...

  • GlobeNewswire2 months ago

    TearLab Corporation Reports Third Quarter 2018 Financial Results

    ESCONDIDO, Calif., Nov. 07, 2018 -- TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”) today reported its consolidated financial results for the third quarter ended.

  • Associated Press5 months ago

    TearLab: 2Q Earnings Snapshot

    On a per-share basis, the San Diego-based company said it had a loss of 6 cents. The ophthalmic device company posted revenue of $6.4 million in the period. In the final minutes of trading on Thursday, ...

  • ACCESSWIRE11 months ago

    Today’s Research Reports on Aphria, Centric Health, Helix BioPharma and TearLab

    NEW YORK, NY / ACCESSWIRE / February 23, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...